- Home
- FNWD vs SGMO Comparison
FNWD vs SGMO Comparison
Compare FNWD & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWD | SGMO |
|---|---|---|
| Founded | 1994 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.0M | 135.1M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | FNWD | SGMO |
|---|---|---|
| Price | $38.74 | $0.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $34.00 | $5.60 |
| AVG Volume (30 Days) | 19.5K | ★ 4.3M |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $66,563,999.00 | $32,875,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.03 | N/A |
| P/E Ratio | $19.87 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.12 | $0.37 |
| 52 Week High | $39.99 | $1.40 |
Technical Indicators
Market Signals| Indicator | FNWD | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 59.15 | 41.13 |
| Support Level | $34.12 | $0.37 |
| Resistance Level | $35.36 | $0.48 |
| Average True Range (ATR) | 1.17 | 0.03 |
| MACD | 0.32 | -0.00 |
| Stochastic Oscillator | 75.54 | 30.36 |
Price Performance
Historical ComparisonAbout FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.